SenoRx, Inc.Aliso Viejo, CA, United States (NASDAQ (GM): SENO)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

SenoRx Financial Statements

SenoRx Financial Information

Company Type Public
Single Location
Fiscal Year-End December
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

SenoRx Income Statement

  2007 2006 2005
Revenue ($ mil.) 35.0 25.5 19.3
Gross Profit ($ mil.) 19.9 12.0 9.1
Operating Income ($ mil.) (9.6) (10.4) (8.0)
Total Net Income ($ mil.) (9.9) (15.4) (8.6)
Diluted EPS (Net Income) (0.75) (6.61) (1.20)
More SenoRx financial information

SenoRx Stock Quote & Chart

09/05/08 14:43:12 EST • NASDAQ • 5.85 • Increased by +0.0200 • Increased by +0.3431 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

SenoRx Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 2.91 2.20 1.54
Price/Earnings Ratio 214.00 21.53 15.62
Price/Book Ratio 3.36 2.18 1.49
Price/Cash Flow Ratio -- 15.86 9.59
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed SenoRx Financial Ratios

SenoRx Competitive Intelligence

Bard Hologic Johnson & Johnson
Annual Sales ($ mil.) 2,202.0 738.4 61,095.0
Employees 10,200 3,580 119,200
Market Cap ($ mil.) 9,379.7 5,164.9 198,797.7

Competitive Landscape